We appreciate the opportunity to provide you with this resource and look forward to your feedback. Eligibility for services is determined with this initial call. If eligible, patients are then surveyed for their history of tobacco use, pervious attempts in stopping, etc. The Quitline staff will then make a recommendation on whether NWT is needed and authorize therapy. Drug products must be authorized through the QuitLine.
Patients are unsure of how to use some of the medications.
No one medication is better than another. NWT should be selected based on the patient s nicotine use characteristics and comfort with the medication. Patients should indicate a high degree of motivation prior to a cessation attempt, because no medication will provide this. Although this type of generalization can result in pharmaceutical costs being higher than desired, use of any of these products doubles quit rates compared to placebo. Use of pharmacological therapy should be encouraged if you think it will provide support for the patient s quit attempts.